FABP1 and acute kidney injury: The present study has demonstrated that urinary L-FABP on admission predicts long-term adverse outcomes in a large (n = 1119), heterogeneous cohort of patients treated at medical CICUs and that the combination of increased L-FABP and creatinine-defined AKI status improves the long-term risk stratification of patients hospitalized at medical CICUs.